Fabry and Cardiomyopathy (FaCard) Epidemiological Study for the Analysis of Biomarkers and the Clinical Course of Patients With Fabry Disease and the N215S-mutation "FaCard"


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- All patients of both gender from 18 years of age with a diagnosis of Fabry disease with the mutation N215S
- Written informed consent from patient

Exclusion Criteria

- Patients without a diagnosis of Fabry disease
- No written informed consent